Evidence map›Paper›PMID 25923984›Full record

ArticleKidney international2015

High cardiovascular event rates occur within the first weeks of starting hemodialysis.

Kai-Uwe Eckardt, Iain A Gillespie, Florian Kronenberg, Sharon Richards, Peter Stenvinkel, Stefan D Anker, David C Wheeler, Angel L de Francisco, Daniele Marcelli, Marc Froissart and 2 more

Abstract read
In one paragraph

Article in Kidney international, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Trial
  5. Trial
  6. Roxadustat (FG-4592): Correction of Anemia in Incident Dialysis Patients.Journal of the American Society of Nephrology : JASN · 2016
    Trial
  7. Ten tips for the first hemodialysis sessions.Clinical kidney journal · 2026
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Review
  14. Article
  15. Patient-focused outcomes after initiation of dialysis for ESRD: mortality, hospitalization and functional impairment.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2023
    Observational
  16. Time-Dependent Factors Influencing Cardiocerebral Vascular Events in Chronic Hemodialysis Patients: Insights from a Longitudinal Study.Medical science monitor : international medical journal of experimental and clinical research · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Kai-Uwe EckardtDepartment of Nephrology and Hypertension, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany.
Iain A GillespieAmgen, Uxbridge, UK.
Florian KronenbergDivision of Genetic Epidemiology, Department of Medical Genetics, Molecular and Clinical Pharmacology, Medical University of Innsbruck, Innsbruck, Austria.
Sharon RichardsAmgen, Uxbridge, UK.
Peter StenvinkelDepartment of Renal Medicine, Karolinska University Hospital Huddinge, Stockholm, Sweden.
Stefan D AnkerDepartment of Innovative Clinical Trials, University Medical Centre, Göttingen, Germany.
David C WheelerDivision of Medicine, University College London, London, UK.
Angel L de FranciscoServicio de Nefrología, Hospital Universitario Valdecilla, Universidad de Cantabria, Santander, Spain.
Daniele MarcelliFresenius Medical Care (Europe), Bad Homburg, Germany.
Marc FroissartAmgen Europe GmbH, Zug, Switzerland.
Jürgen FloegeDivision of Nephrology and Immunology, Department of Medicine, RWTH University of Aachen, Aachen, Germany.
ARO Steering Committee

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Early mortality is high in hemodialysis (HD) patients, but little is known about early cardiovascular event (CVE) rates after HD initiation. To study this we analyzed data in the AROii cohort of incident HD patients from over 300 European Fresenius Medical Care dialysis centers. Weekly rates of a composite of CVEs during the first year and monthly rates of the composite and its constituents (coronary artery, cerebrovascular, peripheral arterial, congestive heart failure, and sudden cardiac death) during the first 2 years after HD initiation were assessed. Of 6308 patients that started dialysis within 7 days, 1449 patients experienced 2405 CVEs over the next 2 years. The first-year CVE rate (30.2/100 person-years; 95% CI, 28.7-31.7) greatly exceeded the second-year rate (19.4/100; 95% CI, 18.1-20.8). Composite CVEs were highest during the first week with increased risk compared with the second year, persisting until the fifth month. Except for sudden cardiac death, temporal patterns of rates for all CVE categories were very similar, with highest rates during the first month and a high-risk period extending to 4 months. Higher or lower cumulative weekly dialysis dose, lower blood flow, and lower net ultrafiltration during dialysis were associated with CVE during the high-risk period, but not during the post high-risk period. Thus, the incidence of CVE in the first weeks after HD initiation is much higher than during subsequent periods which raises concerns that HD initiation may trigger CVEs.

Indexed as

AgedAged, 80 and overCardiovascular DiseasesCoronary DiseaseDeath, Sudden, CardiacFemaleHeart FailureHumansIncidenceMaleMiddle AgedPeripheral Arterial DiseaseRenal DialysisRenal Insufficiency, ChronicRisk FactorsStroke

Identifiers

PMID25923984
PMCPMC4653589

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.